Quantitative PCR assesses tumor cell ratios in chemotherapy-resistant ovarian cancer, indicating potential for long-term control.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hockings et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: